STOCK TITAN
  1. Home
  2. Sec-filings
  3. HLXB
  4. [EFFECT] Helix Acquisition Corp. II SEC Filing

[EFFECT] Helix Acquisition Corp. II SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 10, 2025 4:15 P.M.
Form: S-4
CIK: 0001869105
Company Name: Helix Acquisition Corp. II
File Number: 333-288222
CIK: 0002022953
Company Name: TheRas, Inc.
File Number: 333-288222-01

Source: View Original Filing on SEC EDGAR

Helix Acqsn II

NASDAQ:HLXB

View HLXB Stock Overview →

HLXB Rankings

#4336 Ranked by Market Cap
N/A Ranked by Dividends

HLXB Latest News

Aug 6, 2025
Helix Acquisition Corp. II Retains More than 60% of Trust Account after Redemptions in connection with Business Combination with BridgeBio Oncology Therapeutics
Jul 11, 2025
Helix Acquisition Corp. II and BridgeBio Oncology Therapeutics Announce Effectiveness of Registration Statement for Proposed Business Combination
Feb 28, 2025
BridgeBio Oncology Therapeutics (BBOT) and Helix Acquisition Corp. II Announce Business Combination Agreement to Create Publicly Listed Biotechnology Company Advancing a Pipeline of RAS and PI3Kα-Targeting Medicines
Feb 14, 2024
Helix Acquisition Corp. II Announces Closing of $184 Million Initial Public Offering, Including the Full Exercise of the Underwriter';s Option to Purchase Additional Shares
Feb 9, 2024
Helix Acquisition Corp. II Announces Pricing of Upsized $160 Million Initial Public Offering

HLXB Latest SEC Filings

Sep 3, 2025
[SCHEDULE 13G] Helix Acquisition Corp. II SEC Filing
Aug 29, 2025
[S-1] Helix Acquisition Corp. II Files IPO Registration Statement
Aug 28, 2025
[Form 4] Helix Acquisition Corp. II Insider Trading Activity
Aug 28, 2025
[Form 4] Helix Acquisition Corp. II Insider Trading Activity
Aug 28, 2025
[Form 4] Helix Acquisition Corp. II Insider Trading Activity

HLXB Stock Data

232.74M
10.02M
Shell Companies
Pharmaceutical Preparations
United States
BOSTON